Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups
In Brief: AACR To Have Fur Symposia, Including One With ASCO; McConnell Names TRTP Director
LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita
Cancer Education Applications Suspended Pending Restructuring
Caution Advised for Hormone Replacement Therapy
NLMs Grateful MED Aids Data Searches
FDA Committee Approves NDA for Mitxantrone
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research
- In The Headlines: Are cancer registries on the chopping block, and what does it mean if they are?
- AACI letter to NIH’s Bhattacharya opposes centralizing review of CCSG